J Clin Aesthet Dermatol. 2025;18(1):24–28. by Naiem T. Issa, MD, PhD, and Lidia Pomaville, PA-C, MPAS  Dr. Issa is with Forefront Dermatology in Vienna, Virginia; Issa Research and Consulting, LLC in Springfield, Virginia; the University of Miami Leonard M. Miller School of Medicine in Miami, Florida; and the George Washington University School of Medicine and Health Sciences in Washington, District of Columbia. Ms. Pomaville is with Forefront Dermatology in Berwyn, Illinois; the Marquette University College of Health Sciences, PA Studies Program in Milwaukee, Wisconsin; and the University of Dubuque, MSPAS Program, in Dubuque, Iowa. FUNDING: Research and editorial support for this case series was funded by Dermavant Sciences, Inc.   DISCLOSURES: Dr. Issa has served as an advisor, consultant, speaker, or investigator for Dermavant Sciences, Inc.; Dr. Pomaville reports no relevant conflicts of interest. ABSTRACT: Seborrheic dermatitis (SD) is an inflammatory skin disease with multifacto

J Clin Aesthet Dermatol. 2024;17(12):18–22. by Anisha Bhanot, MD; Jamalje Bassue, MD; Sherifat Ademola, MD; Brigitte Sallee, MD; and Pamela Allen, MD Drs. Bhanot, Sallee, and Allen are with the The University of Oklahoma Department of Dermatology in Norman, Oklahoma. Dr. Bassue is with the Tulane School of Medicine in New Orleans, Louisiana. Dr. Ademola is with the Boston Medical Center in Boston, Massachusetts. FUNDING: No funding was provided for this article. DISCLOSURES: The authors report no conflicts of interest relevant to the content of this article. ABSTRACT: Objective: The authors sought to compare the results in Fitzpatrick Skin Type (FST) reporting among providers, trainees, and patients. They discussed the implications of discordance in FST reporting among these groups. Methods: This survey-based study was offered to all adult patients (18 years or older), dermatology residents, and dermatology faculty providers at University of Oklahoma Dermatology Clinic in Oklahoma City

J Clin Aesthet Dermatol. 2024;17(12):23–24. by Dante Dahabreh, BA; Ezra Hazan, MD, and Hooman Khorasani, MD Mr. Dahabreh and Drs. Hazan and Khorasani are with the Department of Dermatology, Icahn School of Medicine at the Mount Sinai Medical Center in New York, New York. FUNDING: No funding was provided for this article.  DISCLOSURES: The authors report no conflicts of interest relevant to the content of this article. ABSTRACT: V-to-Y advancement flap is a successful repair technique that preserves vascular and tissue integrity adopted after Mohs micrographic surgery to repair cutaneous defects on the head and neck. However, defects at the lateral distal nasal ala requires large extension beyond cosmetic margins that increase risk of skin webbing, an undesired result on a cosmetically sensitive location to the patient. In this article, we present a novel approach to modifying the procedure employing the V-to-Y advancement flap by truncated the trailing end of the island pedicle to allo

J Clin Aesthet Dermatol. 2024;17(12):25–27. by Neena Edupuganti, BA, and Joseph M. Dyer, DO Ms. Edupuganti and Dr. Dyer are with the Philadelphia College of Osteopathic Medicine, Georgia Campus in Suwanee, Georgia. ABSTRACT: Giant cell tumors of tendon sheath (GCTTS), also known as synovialomas, are benign tumors that originate from the fibrous sheath, or soft tissue, that surround tendons. These tumors predominantly present on the hand, but can present in the wrist, ankle, knee, elbow, or hip. The classic presentation of GCTTS is a painless, firm, slow growing mass present for weeks to months. The pathogenesis of GCTTS remains unknown. Histopathological examination of the tumor is required to confirm the diagnosis. The preferred treatment is surgical excision with long-term follow up. To our knowledge, this is the third reported case of GCTTS originating in the subunguium and the first reported case of GCTTS in the subunguium of the toe. Keywords: Giant cell tumor of tendon sheath, sy